G-Protein Receptor Mimicked
University of Bristol
Researchers from the University of Bristol have found a way to mimic the way cells in living organisms ‘talk’ to the world around them by creating a world-first synthetic receptor which can respond to chemical signals just like its natural equivalent.
The breakthrough research, published in the journal Nature Chemistry, paves the way for further advances in biotechnology and in the future could be used in the treatment of medical conditions caused by faulty cellular communication. The research was supported by the European Research Council and the Engineering and Physical Science Research Council (EPSRC).
Professor Jonathan Clayden from the University of Bristol’s School of Chemistry explains: "Cells in living organisms find out what is happening in the world around them by using receptor molecules embedded in their outer membranes. These respond to chemical messages, such as hormones, by changing shape, which sets off a cascade of chemical events inside the cell.
"Working with collaborators in Manchester, we have now designed and synthesized the first artificial mimic of one of these receptors."
The synthetic receptor embeds itself into the membrane of simple cellular structures known as vesicles, and just like its natural equivalent, changes its molecular shape in response to chemical signals.
The researchers were able to get the receptor mimic to respond to the natural hormone Leu-enkephalin (an “agonist”), which in humans is involved in pain relief, and were able to use another chemical messenger (an “antagonist”) to switch this response off again.
"The discovery that artificial molecules can respond to chemical signals in this way raises the possibility that the natural communication pathways used by cells could be added to or bypassed," said Professor Clayden.
"Ultimately, we could see artificial cells being used to produce valuable materials or medicines under the control of receptors in their membranes, or the use of artificial receptors to treat medical conditions caused by faulty cellular communications."
This article has been republished from materials provided by The University of Bristol. Note: material may have been edited for length and content. For further information, please contact the cited source.
Lister, F., Le Bailly, B., Webb, S. and Clayden, J. (2017). Ligand-modulated conformational switching in a fully synthetic membrane-bound receptor. Nature Chemistry.
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE